Profil
Dr. Bianca Ogden is a Portfolio Manager at Platinum Investment Management Ltd. Ms. Ogden embarked on a career change in 2003 and joined Platinum as an Investment Analyst.
Her rich knowledge base in molecular biology and first-hand insights into the pharmaceutical and biotech industry give her a unique ability to delve deeply into the fundamentals of healthcare companies and identify those with a solid foundation in scientific research.
She also leads the healthcare sector team.
After spending some time at Swiss pharmaceuticals company Novartis researching new HIV drugs (one of which has been approved and is in use today), she went on to complete a PhD at UCL, investigating Kaposi’s sarcoma-associated herpesvirus.
She then migrated to Australia and joined Johnson & Johnson as a molecular biologist, researching new drug targets in oncology.
She holds a Master of Biology degree at Tuebingen and a PhD from University College London.
Postes actifs de Bianca Ogden
| Sociétés | Poste | Début |
|---|---|---|
Platinum Investment Management Ltd.
Platinum Investment Management Ltd. Investment ManagersFinance Platinum is an active, contrarian investment manager that focuses on one asset class – international shares. The firm aims to achieve absolute returns over the long term for their investors by investing in undervalued listed (and unlisted) investments around the world. They adopt a bottom-up stock selection methodology, through which long-term capital growth is sought by investing in undervalued securities around the world. | Directeur de la Recherche - Actions | 01/01/2003 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Platinum Investment Management Ltd.
Platinum Investment Management Ltd. Investment ManagersFinance Platinum is an active, contrarian investment manager that focuses on one asset class – international shares. The firm aims to achieve absolute returns over the long term for their investors by investing in undervalued listed (and unlisted) investments around the world. They adopt a bottom-up stock selection methodology, through which long-term capital growth is sought by investing in undervalued securities around the world. | Finance |
















